VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Kubota Corporation vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Kubota Corporation
6326 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Kubota Corporation's moat claims, evidence, and risks.
View 6326 analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 73 / 100 for Kubota Corporation).
- Segment focus: Kubota Corporation has 3 segments (87.4% in Farm & Industrial Machinery); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Kubota Corporation has 6 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Kubota Corporation
Farm & Industrial Machinery
Agricultural machinery and compact construction equipment (incl. compact/utility tractors, construction machinery, engines)
Global
Dealers and end users (farmers, contractors, municipalities)
OEM
87.4%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Kubota Corporation strengths
Novo Nordisk A/S strengths
Segment mix
Kubota Corporation segments
Full profile >Farm & Industrial Machinery
Oligopoly
Water & Environment
Competitive
Other
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.